This report contains market size and forecasts of Gastroparesis Drugs in global, including the following market information:
Global Gastroparesis Drugs Market Revenue, 2016-2021, 2022-2027, ($ millions)
Global Gastroparesis Drugs Market Sales, 2016-2021, 2022-2027, (Kg)
Global top five Gastroparesis Drugs companies in 2020 (%)
The global Gastroparesis Drugs market was valued at 5595.6 million in 2020 and is projected to reach US$ 6575.1 million by 2027, at a CAGR of 4.1% during the forecast period.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Gastroparesis Drugs manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Gastroparesis Drugs Market, By Type, 2016-2021, 2022-2027 ($ Millions) & (Kg)
Global Gastroparesis Drugs Market Segment Percentages, By Type, 2020 (%)
Prokinetic Agents
Antiemetic Agents
Others
Global Gastroparesis Drugs Market, By Application, 2016-2021, 2022-2027 ($ Millions) & (Kg)
Global Gastroparesis Drugs Market Segment Percentages, By Application, 2020 (%)
Diabetic Gastroparesis
Idiopathic Gastroparesis
Global Gastroparesis Drugs Market, By Region and Country, 2016-2021, 2022-2027 ($ Millions) & (Kg)
Global Gastroparesis Drugs Market Segment Percentages, By Region and Country, 2020 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Gastroparesis Drugs revenues in global market, 2016-2021 (Estimated), ($ millions)
Key companies Gastroparesis Drugs revenues share in global market, 2020 (%)
Key companies Gastroparesis Drugs sales in global market, 2016-2021 (Estimated), (Kg)
Key companies Gastroparesis Drugs sales share in global market, 2020 (%)
Further, the report presents profiles of competitors in the market, key players include:
Sumitomo
Cadila Pharmaceuticals
Sanofi
Teva
Johnson & Johnson
Pfizer
Kyowa Kirin Pharmaceuticals
Hanmi Pharm
Ani Pharmaceuticals
Table of Contents
1 Introduction to Research & Analysis Reports
1.1 Gastroparesis Drugs Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Gastroparesis Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Gastroparesis Drugs Overall Market Size
2.1 Global Gastroparesis Drugs Market Size: 2021 VS 2027
2.2 Global Gastroparesis Drugs Revenue, Prospects & Forecasts: 2016-2027
2.3 Global Gastroparesis Drugs Sales (Consumption): 2016-2027
3 Company Landscape
3.1 Top Gastroparesis Drugs Players in Global Market
3.2 Top Global Gastroparesis Drugs Companies Ranked by Revenue
3.3 Global Gastroparesis Drugs Revenue by Companies
3.4 Global Gastroparesis Drugs Sales by Companies
3.5 Global Gastroparesis Drugs Price by Manufacturer (2016-2021)
3.6 Top 3 and Top 5 Gastroparesis Drugs Companies in Global Market, by Revenue in 2020
3.7 Global Manufacturers Gastroparesis Drugs Product Type
3.8 Tier 1, Tier 2 and Tier 3 Gastroparesis Drugs Players in Global Market
3.8.1 List of Global Tier 1 Gastroparesis Drugs Companies
3.8.2 List of Global Tier 2 and Tier 3 Gastroparesis Drugs Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Gastroparesis Drugs Market Size Markets, 2021 & 2027
4.1.2 Prokinetic Agents
4.1.3 Antiemetic Agents
4.1.4 Others
4.2 By Type - Global Gastroparesis Drugs Revenue & Forecasts
4.2.1 By Type - Global Gastroparesis Drugs Revenue, 2016-2021
4.2.2 By Type - Global Gastroparesis Drugs Revenue, 2022-2027
4.2.3 By Type - Global Gastroparesis Drugs Revenue Market Share, 2016-2027
4.3 By Type - Global Gastroparesis Drugs Sales & Forecasts
4.3.1 By Type - Global Gastroparesis Drugs Sales, 2016-2021
4.3.2 By Type - Global Gastroparesis Drugs Sales, 2022-2027
4.3.3 By Type - Global Gastroparesis Drugs Sales Market Share, 2016-2027
4.4 By Type - Global Gastroparesis Drugs Price (Manufacturers Selling Prices), 2016-2027
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Gastroparesis Drugs Market Size, 2021 & 2027
5.1.2 Diabetic Gastroparesis
5.1.3 Idiopathic Gastroparesis
5.2 By Application - Global Gastroparesis Drugs Revenue & Forecasts
5.2.1 By Application - Global Gastroparesis Drugs Revenue, 2016-2021
5.2.2 By Application - Global Gastroparesis Drugs Revenue, 2022-2027
5.2.3 By Application - Global Gastroparesis Drugs Revenue Market Share, 2016-2027
5.3 By Application - Global Gastroparesis Drugs Sales & Forecasts
5.3.1 By Application - Global Gastroparesis Drugs Sales, 2016-2021
5.3.2 By Application - Global Gastroparesis Drugs Sales, 2022-2027
5.3.3 By Application - Global Gastroparesis Drugs Sales Market Share, 2016-2027
5.4 By Application - Global Gastroparesis Drugs Price (Manufacturers Selling Prices), 2016-2027
6 Sights by Region
6.1 By Region - Global Gastroparesis Drugs Market Size, 2021 & 2027
6.2 By Region - Global Gastroparesis Drugs Revenue & Forecasts
6.2.1 By Region - Global Gastroparesis Drugs Revenue, 2016-2021
6.2.2 By Region - Global Gastroparesis Drugs Revenue, 2022-2027
6.2.3 By Region - Global Gastroparesis Drugs Revenue Market Share, 2016-2027
6.3 By Region - Global Gastroparesis Drugs Sales & Forecasts
6.3.1 By Region - Global Gastroparesis Drugs Sales, 2016-2021
6.3.2 By Region - Global Gastroparesis Drugs Sales, 2022-2027
6.3.3 By Region - Global Gastroparesis Drugs Sales Market Share, 2016-2027
6.4 North America
6.4.1 By Country - North America Gastroparesis Drugs Revenue, 2016-2027
6.4.2 By Country - North America Gastroparesis Drugs Sales, 2016-2027
6.4.3 US Gastroparesis Drugs Market Size, 2016-2027
6.4.4 Canada Gastroparesis Drugs Market Size, 2016-2027
6.4.5 Mexico Gastroparesis Drugs Market Size, 2016-2027
6.5 Europe
6.5.1 By Country - Europe Gastroparesis Drugs Revenue, 2016-2027
6.5.2 By Country - Europe Gastroparesis Drugs Sales, 2016-2027
6.5.3 Germany Gastroparesis Drugs Market Size, 2016-2027
6.5.4 France Gastroparesis Drugs Market Size, 2016-2027
6.5.5 U.K. Gastroparesis Drugs Market Size, 2016-2027
6.5.6 Italy Gastroparesis Drugs Market Size, 2016-2027
6.5.7 Russia Gastroparesis Drugs Market Size, 2016-2027
6.5.8 Nordic Countries Gastroparesis Drugs Market Size, 2016-2027
6.5.9 Benelux Gastroparesis Drugs Market Size, 2016-2027
6.6 Asia
6.6.1 By Region - Asia Gastroparesis Drugs Revenue, 2016-2027
6.6.2 By Region - Asia Gastroparesis Drugs Sales, 2016-2027
6.6.3 China Gastroparesis Drugs Market Size, 2016-2027
6.6.4 Japan Gastroparesis Drugs Market Size, 2016-2027
6.6.5 South Korea Gastroparesis Drugs Market Size, 2016-2027
6.6.6 Southeast Asia Gastroparesis Drugs Market Size, 2016-2027
6.6.7 India Gastroparesis Drugs Market Size, 2016-2027
6.7 South America
6.7.1 By Country - South America Gastroparesis Drugs Revenue, 2016-2027
6.7.2 By Country - South America Gastroparesis Drugs Sales, 2016-2027
6.7.3 Brazil Gastroparesis Drugs Market Size, 2016-2027
6.7.4 Argentina Gastroparesis Drugs Market Size, 2016-2027
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Gastroparesis Drugs Revenue, 2016-2027
6.8.2 By Country - Middle East & Africa Gastroparesis Drugs Sales, 2016-2027
6.8.3 Turkey Gastroparesis Drugs Market Size, 2016-2027
6.8.4 Israel Gastroparesis Drugs Market Size, 2016-2027
6.8.5 Saudi Arabia Gastroparesis Drugs Market Size, 2016-2027
6.8.6 UAE Gastroparesis Drugs Market Size, 2016-2027
7 Manufacturers & Brands Profiles
7.1 Sumitomo
7.1.1 Sumitomo Corporate Summary
7.1.2 Sumitomo Business Overview
7.1.3 Sumitomo Gastroparesis Drugs Major Product Offerings
7.1.4 Sumitomo Gastroparesis Drugs Sales and Revenue in Global (2016-2021)
7.1.5 Sumitomo Key News
7.2 Cadila Pharmaceuticals
7.2.1 Cadila Pharmaceuticals Corporate Summary
7.2.2 Cadila Pharmaceuticals Business Overview
7.2.3 Cadila Pharmaceuticals Gastroparesis Drugs Major Product Offerings
7.2.4 Cadila Pharmaceuticals Gastroparesis Drugs Sales and Revenue in Global (2016-2021)
7.2.5 Cadila Pharmaceuticals Key News
7.3 Sanofi
7.3.1 Sanofi Corporate Summary
7.3.2 Sanofi Business Overview
7.3.3 Sanofi Gastroparesis Drugs Major Product Offerings
7.3.4 Sanofi Gastroparesis Drugs Sales and Revenue in Global (2016-2021)
7.3.5 Sanofi Key News
7.4 Teva
7.4.1 Teva Corporate Summary
7.4.2 Teva Business Overview
7.4.3 Teva Gastroparesis Drugs Major Product Offerings
7.4.4 Teva Gastroparesis Drugs Sales and Revenue in Global (2016-2021)
7.4.5 Teva Key News
7.5 Johnson & Johnson
7.5.1 Johnson & Johnson Corporate Summary
7.5.2 Johnson & Johnson Business Overview
7.5.3 Johnson & Johnson Gastroparesis Drugs Major Product Offerings
7.5.4 Johnson & Johnson Gastroparesis Drugs Sales and Revenue in Global (2016-2021)
7.5.5 Johnson & Johnson Key News
7.6 Pfizer
7.6.1 Pfizer Corporate Summary
7.6.2 Pfizer Business Overview
7.6.3 Pfizer Gastroparesis Drugs Major Product Offerings
7.6.4 Pfizer Gastroparesis Drugs Sales and Revenue in Global (2016-2021)
7.6.5 Pfizer Key News
7.7 Kyowa Kirin Pharmaceuticals
7.7.1 Kyowa Kirin Pharmaceuticals Corporate Summary
7.7.2 Kyowa Kirin Pharmaceuticals Business Overview
7.7.3 Kyowa Kirin Pharmaceuticals Gastroparesis Drugs Major Product Offerings
7.4.4 Kyowa Kirin Pharmaceuticals Gastroparesis Drugs Sales and Revenue in Global (2016-2021)
7.7.5 Kyowa Kirin Pharmaceuticals Key News
7.8 Hanmi Pharm
7.8.1 Hanmi Pharm Corporate Summary
7.8.2 Hanmi Pharm Business Overview
7.8.3 Hanmi Pharm Gastroparesis Drugs Major Product Offerings
7.8.4 Hanmi Pharm Gastroparesis Drugs Sales and Revenue in Global (2016-2021)
7.8.5 Hanmi Pharm Key News
7.9 Ani Pharmaceuticals
7.9.1 Ani Pharmaceuticals Corporate Summary
7.9.2 Ani Pharmaceuticals Business Overview
7.9.3 Ani Pharmaceuticals Gastroparesis Drugs Major Product Offerings
7.9.4 Ani Pharmaceuticals Gastroparesis Drugs Sales and Revenue in Global (2016-2021)
7.9.5 Ani Pharmaceuticals Key News
8 Global Gastroparesis Drugs Production Capacity, Analysis
8.1 Global Gastroparesis Drugs Production Capacity, 2016-2027
8.2 Gastroparesis Drugs Production Capacity of Key Manufacturers in Global Market
8.3 Global Gastroparesis Drugs Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Gastroparesis Drugs Supply Chain Analysis
10.1 Gastroparesis Drugs Industry Value Chain
10.2 Gastroparesis Drugs Upstream Market
10.3 Gastroparesis Drugs Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Gastroparesis Drugs Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
List of Tables
Table 1. Key Players of Gastroparesis Drugs in Global Market
Table 2. Top Gastroparesis Drugs Players in Global Market, Ranking by Revenue (2019)
Table 3. Global Gastroparesis Drugs Revenue by Companies, (US$, Mn), 2016-2021
Table 4. Global Gastroparesis Drugs Revenue Share by Companies, 2016-2021
Table 5. Global Gastroparesis Drugs Sales by Companies, (Kg), 2016-2021
Table 6. Global Gastroparesis Drugs Sales Share by Companies, 2016-2021
Table 7. Key Manufacturers Gastroparesis Drugs Price (2016-2021) & (US$/mg)
Table 8. Global Manufacturers Gastroparesis Drugs Product Type
Table 9. List of Global Tier 1 Gastroparesis Drugs Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Gastroparesis Drugs Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. By Type
Sumitomo
Cadila Pharmaceuticals
Sanofi
Teva
Johnson & Johnson
Pfizer
Kyowa Kirin Pharmaceuticals
Hanmi Pharm
Ani Pharmaceuticals